News Conference News ESC 2025 HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients Caitlin E. Cox September 01, 2025
News Daily News Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding L.A. McKeown May 16, 2025
News Daily News High-Sensitivity Troponins May Overestimate PE Severity L.A. McKeown November 28, 2023
News Daily News Hormonal Birth Control, NSAID Use Together Linked to VTE Caitlin E. Cox September 11, 2023
News Daily News Don’t Skimp on Anticoagulation in Isolated Distal DVT: RIDTS Todd Neale December 01, 2022
News Daily News Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest Michael O'Riordan October 20, 2022
News Daily News Enoxaparin Tops Aspirin for Preventing VTE After Hip or Knee Arthroplasty Todd Neale August 25, 2022
News Daily News Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients L.A. McKeown June 29, 2022
News Daily News Antithrombotics No Help for Stable COVID-19 Outpatients: ACTIV-4b Shelley Wood June 22, 2021
News Daily News VTE Related to SARS-CoV-2 Infection Less of a Problem in Outpatients Todd Neale April 06, 2021
News Daily News EXTRACT-PE: Positive Results With Aspiration Thrombectomy for Submassive PE Todd Neale January 15, 2021
News Conference News TCT 2020 Interventionalists, Including PERTs, Grapple With VTE Risks of COVID-19 Michael O'Riordan October 14, 2020
News Conference News ESC 2020 HESTIA, Simplified PESI Comparable for Triage to Outpatient PE Treatment: HOME-PE Todd Neale September 01, 2020
News Daily News Systemic Anticoagulation Linked to Lower Mortality in Hospitalized COVID-19 Michael O'Riordan August 28, 2020
News Daily News New AHA Guidance on Hospital VTE Stresses Risk Assessment, Standardization Yael L. Maxwell May 12, 2020
News Conference News ESC 2019 ESC Updates Guidance on Management of Acute Pulmonary Embolism Todd Neale September 06, 2019
News Opinion Off Script Off Script: Through ‘Paclitaxelgate,’ Some Upsides to Uncertainty Sahil Parikh, MD July 29, 2019
News Daily News VTE Risk in Women May Be Higher With Oral vs Transdermal Hormone Replacement Therapies L.A. McKeown January 14, 2019